Overview Financials News + Filings Key Docs Ownership Insiders
|
AN2 Therapeutics, Inc.
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-21 | Dec-31-20 |
| Source | Source |
Turnover Ratios |
Asset turnover | 0.5 | |
|
Returns on Capital |
ROIC (excluding intangibles) | -87.5% | |
ROIC (including intangibles) | -42.8% | 667.3% |
ROE | -34.8% | -264.8% |
ROA | -33.0% | -172.0% |
|
Cash Conversion Cycle |
Days sales outstanding | 0.0 | 0.0 |
Days payables outstanding | 18.0 | 6.6 |
Cash conversion cycle | -18.0 | -6.6 |
|